Researchers conducted an integrative analysis and lab tests using LNCaP cells, which are a type of cell used to study prostate cancer. The goal was to see how arecoline interacts with the body at a molecular level. They found that arecoline is linked to several pathways involved in cell growth and survival.
The study identified 97 overlapping targets related to specific biological pathways. Most importantly, the researchers identified the androgen receptor as a key gene involved in these changes. When cells were treated with arecoline, they showed an increase in both the mRNA and protein levels of this receptor.
It is important to note that this research was conducted in a lab setting using cell cultures, not in humans. Because it is a computer-based and laboratory model, the results are currently used to generate new ideas for future research. These findings do not prove that arecoline causes prostate cancer in people or provide a basis for medical treatment.